CPI-203

Basic Information

CAS ID: 1446144-04-2
Molecular Formula: C19H18ClN5OS
Molecular Weight: 399.897 g/mol
Monoisotopic Mass: 399.092 g/mol
Class: Small Molecule
Natural Product: No
Other Names: 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-2,3,9-trimethyl-, (6S)-|(6S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide|CPI 267203|RG 6146|TEN 010
Analysis: Drug repositioning mechanism analysis

S N N N N O NH2 Cl

Compound Structure and Identifier

InChI: InChI=1S/C19H18ClN5OS/c1-9-10(2)27-19-16(9)17(12-4-6-13(20)7-5-12)22-14(8-15(21)26)18-24-23-11(3)25(18)19/h4-7,14H,8H2,1-3H3,(H2,21,26)/t14-/m0/s1 See All
InChI Key: QECMENZMDBOLDR-AWEZNQCLSA-N
Smiles: CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)N)C4=CC=C(C=C4)Cl)C See All
Molfile: Download

Related Target

Target ID Name Interaction
T1064 Bromodomain and extraterminal domain inhibitor

Related Fibrosis Property

Reference Record 1

PubMed ID 27517095 Target ID T1064
Uniprot ID Bromodomain and extraterminal domain Name Bromodomain and extraterminal domain
Model vitro,mice Fibrosis Disease Cystic fibrosis
Process I attenue inflammation
Process II
Process III
Mechanism

Related Link

PubChem: 71291068
ChEMBL: